Stemtech Financial Statements From 2010 to 2025
| STEK Stock | USD 0 0.0002 14.29% |
Check Stemtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stemtech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Stemtech financial statements analysis is a perfect complement when working with Stemtech Valuation or Volatility modules.
Stemtech |
Stemtech OTC Stock Return On Asset Analysis
Stemtech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Stemtech Return On Asset | -0.75 |
Most of Stemtech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stemtech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Stemtech has a Return On Asset of -0.7542. This is 91.38% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is notably higher than that of the company.
Stemtech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stemtech's current stock value. Our valuation model uses many indicators to compare Stemtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stemtech competition to find correlations between indicators driving Stemtech's intrinsic value. More Info.Stemtech is rated below average in return on asset category among its peers. It is rated fifth in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stemtech's earnings, one of the primary drivers of an investment's value.About Stemtech Financial Statements
Stemtech investors utilize fundamental indicators, such as revenue or net income, to predict how Stemtech OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. Stemtech Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Stemtech OTC Stock
Stemtech financial ratios help investors to determine whether Stemtech OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemtech with respect to the benefits of owning Stemtech security.